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Background: Azithromycin monohydrate is an antibiotic, which belongs to the category of macrolide antibiotics. It
is used for an effective antibiotic for the treatment of sexually transmitted diseases, upper and lower respiratory tract
infections and skin structure infections.
Methods: A gas chromatographic–mass spectrometric (GC–MS) method is described for the determination of
azithromycin monohydrate residue in biological fluids. This method allows detection of residual azithromycin
(AZM) in biological fluids by using single-ion monitoring (SIM). The confirmation by a full-scan electron impact
(EI) mass spectrum is possible if residual level in a sample is >5 μg/mL. AZM is extracted with chloroform from a
sample and cleaned up by n-hexane washing followed by partition between chloroform and phosphate buffer
solution. The cleaned up extract is acetylated in acetic anhydride–pyridine mixture (1:2) at room temperature.
Results: The reaction mixture is injected into the GC–MS apparatus, and the detection has been conducted
using SIM at m/z 200. The detection limit is 2 μg/mL.
Conclusions: This proposed method could be successfully applied to the drug analysis in the forensic laboratories as
well as in the toxicological laboratories.
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Antibiotics are now used extensively in food-producing
animals to maintain optimal health and to promote
growth. The use of these drugs can leave drug residues in
edible tissues. These drug residues may have direct toxic
effects moreover; safety considerations may include aller-
gic reactions of consumers and induction of resistant bac-
teria. Therefore, conditions of use must be established for
animal drugs to assure human food safety as well as effi-
cacy and safety to the animal species (Livingston 1985).
Azithromycin (AZM), with a different chemical entity
(so-called azalide) from the macrolides, is also derived
from erythromycin, but the lactone ring is expanded
from l4-membered to l5-membered, by the incorpor-
ation of nitrogen. As in erythromycin, cladinose and des-
osamine sugar residues are attached at positions 3 and 5.
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netic parameters than erythromycin.
AZM is an effective antibiotic for the treatment of
sexually transmitted diseases, upper and lower respira-
tory tract infections and skin structure infections (Kirst
and Sides 1989). It is also used primarily to treat various
bacterial infections caused by respiratory pathogens, such
as aerobic Gram-positive and Gram-negative bacteria. It
prevents bacterial cells from manufacturing specific pro-
teins necessary for their survival. AZM is rapidly absorbed
and is widely distributed to tissues and becomes concen-
trated in cells. Peak plasma concentrations are achieved
(Debremaeker et al. 2003) within 2 to 3 h.
AZM is obtained from erythromycin, impurities present
will undergo the same modifications and the AZM ana-
logues of these impurities can be found in AZM bulk sam-
ples. In addition, degradation products of AZM as well as
intermediate compounds (Khedr and Sheha 2003) of the
semi-synthesis may be present; for instance, AZM is rap-
idly decomposed in acidic solution via intra-molecular de-
hydration to form erythromycin-6, 6-hemiketal and thenan Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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very difficult to determine (Miguel and Barbas 2003) small
amounts of degradation products in a vast excess of parent
drug and even more so when the compounds do not
present a chromophore as this makes their detection more
difficult.
Chromatographic methods using both thin-layer chro-
matography (TLC) and liquid chromatography (LC) have
been described for the determination of macrolide antibi-
otics. The application of these methods to residue analysis
has been limited. To overcome this lack of sensitivity and
selectivity, TLC and LC methods have been developed; a
review was found on these methods (Moats 1985). How-
ever, TLC methods are capable of qualitative detection of
only one drug in one type of food. LC has also been used
for determination of macrolide antibiotics, but application
to residue analysis has been limited. A stability-indicating
TLC method of the analysis of AZM in bulk and a capsule
form is developed (Khedr and Sheha 2003).
Both coulometric and amperometric methods for the
detection of AZM in human and animal tissues and
serum were used (Shepard et al. 1991). The coulometric
method has since been used by a number of investiga-
tors to characterize the pharmacokinetics of AZM in
humans (Ripa et al. 1996; Conte et al. 1996). HPLC with
ultraviolet detection has been used for the analysis of AZM
in bulk samples, for the separation of related compounds
produced during synthesis and for acid degradation studies.
Methods for the HPLC analysis of AZM in biological
samples have also been described using various methods
of detection in order to overcome the limitations of poor
UV absorbance.
A sensitive HPLC assay using a C18 stationary phase with
detection by atmospheric pressure chemical ionization–
mass spectrometry (APCI–MS) has been developed (Fouda
and Schneider 1995), specifically for the analysis of AZM in
children, which requires only a minute sample volume of
50 μL. A selective reversed-phase liquid chromatography/
mass spectrometry (LC/MS) method has been developed
for the identification of AZM impurities and related sub-
stances in commercial AZM samples (Debremaeker et al.
2003). In comparison with UV detection, this hyphenated
technique provides as its main advantage efficient identifi-
cation of novel substances without time-consuming isola-
tion and purification procedures.
The purpose of this work is to briefly describe mass
spectrometry techniques that are commonly used to
solve toxicological problems. Often a gas chromato-
graphic–mass spectrometric (GC–MS) quantitative assay
is developed and used as a primary standard for evaluation
of less expensive assay methods. Most GC–MS quanti-
tative analyses involve the operation of the mass spec-
trometer in the selected ion monitoring mode (Falkner
et al. 1975).Methods used to determine AZM residue levels include,
but are not limited to, microbiological and chromato-
graphic techniques such as TLC and GC. However, micro-
biological methods lack specificity and TLC methods lack
sensitivity. Microbiological assays are most commonly
used for the measurement of AZM in food, but they are
time consuming, they cannot identify certain macrolides
and their precision appears to be variable. Therefore, a
precise chromatographic analysis method for the macro-
lides has been required.
This paper describes a GC–MS method for the deter-
mination of AZM residue in biological fluids. This
method allows detection of residual AZM in biological
fluids by using single-ion monitoring. This method could
be applied in the forensic laboratories and toxicological
laboratories as well as in pharmaceutical formulations.
Methods
Chemicals and materials
All reagents and solvents used were of analytical grade.
Azithromycin was received from Hindustan Antibiotics
Ltd., Bangalore, India, as a free gift sample. Acetic anhyd-
ride and anhydrous pyridine were obtained from Merck
(Darmstadt, Germany) and was pro analysis grade. De-
ionized, doubly distilled water was used throughout.
TLC silica gel F254 plate was obtained from Merck
(Darmstadt, Germany).
Standard reagents viz. methanol (CH3OH), n-hexane
(n-C6H6), chloroform (CHCl3), sodium hydroxide (NaOH),
sodium chloride (NaCl), sodium sulfate (Na2SO4) and diso-
dium hydrogen phosphate (Na2HPO4·12H2O) all used were
AR grade.
Na2HPO4 solution
One gram of disodium hydrogen phosphate (Na2H-
PO4·12H2O) was taken from a beaker and then dissolved
in 100 mL of doubly distilled water.
NaOH solution
A 5 N sodium hydroxide (NaOH) solution was prepared
using 20 g of NaOH and dissolved in 100 mL of doubly
distilled water.
NaCl solution
Ten grams of sodium chloride (NaCl) was taken from a
beaker and dissolved in 100 mL of doubly distilled water.
Standard solutions
Stock solution
Accurately weighed 100 mg of pure azithromycin mono-
hydrate was dissolved in the methanol; the solution was
made up in the 10-mL standard flask to make the con-
centration 10 mg/mL.
Fig. 1 Acid hydrolysis of azithromycin
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Standard solutions were diluted to 50, 25, 10, 5 and
2 μg/mL concentration with methanol from the above
stock solution. These solutions have been stored in a re-
frigerator with light protection.
Extraction and cleanup
Gastric cleavage samples (10 mL) were taken from a
100-mL centrifuge tube. Then, 20 mL of CH3OH was
added into that, and then it has been homogenized for
10 min. The contents were rinsed twice well with 3 mL
of CH3OH, and the rinses were added into the centri-
fuge tube.
The centrifuge tube has been shaken very well for
10 min. The supernatant solution was filtered through
fluted paper into a 100-mL separatory funnel. Twenty
milliliters of CH3OH was added into the residue; the
centrifuge tube was shaken vigorously for 10 min.
The contents were centrifuged for 10 min at 2000 rpm;
after that, the supernatant solution was filtered through
fluted paper. The filtrate was combined with the first ex-
tract, which is in a 100-mL separatory funnel.
Further, 20 mL of n-hexane was added into the com-
bined CH3OH extract, which is in a separatory funnel, it
has been shaken vigorously for 5 min, and it was set
aside to separate.
The lower CH3OH phase was drained into a second
100-mL separatory funnel, and the upper n-hexane phase
was discarded. Two to three milliliters of 1 N NaOH and
30 mL of CHCl3 were added into the CH3OH phase, and
these were mixed by swirling.
In addition to this, 30 mL of 1 % of Na2HPO4 solution
was also added, and it has been shaken vigorously for
2–3 min. It was set aside to separate for 15–20 min. The
lower CHCl3 phase was drained into a third 100-mL
separatory funnel.
Suppose if two phases do not readily separate after
centrifugation for 5 min at 2000 rpm, we have to add an
additional 30 mL of CHCl3 into the aqueous phase and
it should be extracted again. The CHCl3 extract was
combined into the third 100-mL separatory funnel, and
it was washed with 30 mL of NaCl solution.
The CHCl3 phase has been transferred into a 100-mL




The capillary column was 5 % phenyl methyl silicone,
with 30-m width, 0.25-mm i.d. and 0.25 film thickness.
Gas chromatograph mass spectrometer
The gas chromatograph mass spectrometer was a
PerkinElmer instrument with Autosystem XL GC, turbomass MS, autosampler, 2-μL injection, 200° injection port,
200° interface, 70-eV electron impact (EI) mode and
40–630-amu mass range.
Operating conditions
The operating conditions were as follows: 200° injection
port, 250°C oven isothermal temperature, 1 mL/min carrier
gas helium flow and 70-eV ionization voltage.
Derivatization procedure
For successful GC–MS analysis, the sample must be both
volatile and thermally stable. Many organic compounds do
not fulfil these criteria by virtue of their possessing polar
functional groups. Protecting these functional groups by
derivatization is the normal method for conferring good
GC–MS behaviour. Derivatization is used to increase a
compound’s volatility or its thermal stability to improve its
GC behaviour by substituting lipophilic groups for ‘active’
hydrogens or to advantageously alter the compound’s mass
spectrum (Lin et al. 2008).
The derivatization reactions generally used for GC de-
termination are silylation, acetylation and etherification.
In this work, we have chosen to utilize the acetyl deriva-
tive, because it is easily prepared and stable, and the
increase in molecular weight by derivatization is not so
Fig. 2 Structure for m/z 200 fragmentation of desosamine acetate in
EI mass spectrum of the azithralosamine acetate
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anhydride and pyridine at room temperature. The reac-
tion mixtures were monitored by TLC to ensure the
complete conversion of starting materials. At high tem-
peratures, it was possible to elute azithralosamine acet-
ate as a relatively sharp peak in a reasonable retentionFig. 3 Single-ion chromatogram at m/z 200 for azithralosamine acetatetime. In an autosampler vial, 1 mL of working solution
containing a concentration of 5 μg/mL was pipetted
out. It was evaporated to dry, and the dry residue was
dissolved in 500 μL of anhydrous pyridine; in addition
to the pyridine solution, 250 μL of acetic anhydride was
added and the vial was closed tightly. The residue was
dissolved by swirling and allowed to stand at room
temperature overnight. This sample solution has been
reserved in a refrigerator. This is ready for injection into
the GC–MS apparatus.Evaluation of repeatability, reproducibility and linearity
The repeatability of the derivatization procedure and the
chromatographic analysis was determined by five replicate
injections of the standards prepared as described above.
The reproducibility of the method was determined by five
replicate injections performed within 3 days.
The reproducibility of the derivatization procedure
and the chromatographic analysis was checked by repeti-
tion of the first average separate determinations. The
calibration curves were linear in the tested range up to
500 μg/mL.
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The molecular weight is relatively large (M.W=749) for
AZM. This antibiotic has polar functional groups such
as hydroxyls, carbonyls and sugars. Elution from a GC
column after derivatization was considered to be difficult
and impractical. At first, we intended to obtain the agly-
cone of AZM by hydrolyses of all glycoside linkages.
However, the glycoside linkage of the amino sugar, deso-
samine, resists acid hydrolysis much more than that
of the neutral sugar, cladinose. A condition normally re-
quired for the removal of desosamine from the macro-
lides induces destruction of the aglycone. On the otherFig. 4 Electron impact mass spectrum of azithralosamine acetate (70 eV) ahand, azithralosamine can be easily obtained by mild
acid hydrolysis (Fig. 1) encouraging us to do GC–MS
determination after derivatization.
The conditions of acid hydrolysis for AZM was inves-
tigated using TLC (silica gel F254, dichloromethane:-
methanol = 9:1). But no separation for AZM drugs was
obtained. For this purpose (Wallhäuser KH 1967), a slow
moving solvent mixture containing water and n-butanol
had to be used, needing about 1 h to give an elution zone
of 6 cm. With longer distances, separation of AZM was
not improved. In contrast to dichloromethane:methanol
mixtures, the Rf values of AZM spots did not changet a retention time of 18.43 min
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with n-butanol:water (9:1 v/v) for AZM is 0.42. Optimum
conditions obtained were 0.1 N HCl at room temperature
and overnight reaction time. To shorten the reaction time,
slightly more vigorous conditions were tried. We found
that heating at 50 °C in 0.3 N HCl for 1 h was sufficient to
obtain comparable yield of azithralosamine.
The reproducibility of the derivatization procedure and
the chromatographic analysis was checked by repetition of
the five average separate determinations. The calibration
curves were linear in the tested range up to 500 μg/mL.
The acetylation at an elevated temperature is faster than
that at room temperature. The amount of acetylated prod-
uct decreased to about half after 2 weeks of storage in the
refrigerator. Our experiences indicated that the GC–MS
determination must be performed within 2–3 days after
acetylation.
Azithralosamine acetate was injected into the GC–MS
apparatus, and total ion chromatogram and a full-scan
mass spectrum were obtained. Figure 4 shows the mass
spectrum, in which the base peak of m/z 200 is very prom-
inent and m/z 84, 98, 123, 140, 158, 193, 207, 221, 223,
292, 401, 417, 487, 537 and 592 are observed but relatively
weak. The m/z 200 ion is considered to be the desosamine
acetate ion (Fig. 2). Simultaneous monitoring of three ions
is usually regarded as a minimum for identification by se-
lected ion monitoring of GC–MS spectra (Sphon 1978).
In this work, we attempted to detect azithralosamine acet-
ate using selected ion monitoring at m/z 200, 98, 123, 140,
158, 193, 207 and 221. However, the sensitivity of detec-
tion is much lower (<1/10) than that using single-ion
monitoring (SIM) at m/z 200 only. There are no interfer-
ing peaks on this chromatogram at the retention time of
azithralosamine acetate.
For extraction of AZM from sample tissues, we used
methanol because of the high solubility of macrolides and
the ease of permeability into sample tissues. To remove
coextractives and to clean up the antibiotic, we washed
methanol extract with n-hexane and partitioned between
chloroform and phosphate buffer. Figure 3 shows the SIM
chromatogram of AZM hydrolysis and acetylation at m/z
200. The peak observed is very close to that of azithralosa-
mine acetate. Figure 4 shows the full-scan mass spectrum
of the peak indicated at a retention time of 18.43. However,
many background ions appeared on the full-scan mass
spectrum of this peak and confirmation was not possible.
Conclusions
Although an internal standard is not used in this
method, the separation of the GC column and the sensi-
tivity of SIM detection considered together offer the reli-
able screening of residual AZM in biological fluids, and
a confirmation of the presence of AZM in samples of
high residue level is possible. The focus of our researchhowever has been on methods allowing the confirmation
of AZM in biological fluids. This method could be ap-
plied in the determination of macrolide group of antibi-
otics in forensic samples as well as in toxicological and
in the environmental samples.
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